USD 30.27 billion
Report ID:
SQMIG45J2077 |
Region:
Global |
Published Date: April, 2025
Pages:
157
|Tables:
67
|Figures:
80
Biosensors Market size was valued at USD 30.27 billion in 2023 and is poised to grow from USD 32.72 billion in 2024 to USD 61.02 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).
Biosensors are analytical devices that detect target chemicals or probes by biological reactions that convert cells, tissues, organisms and enzymes into electrical signals. A typical biosensor consists of a bioreceptor that explicitly detects the analyte and a transducer transforming the bio-detection phenomenon into a measurable signal, environmental monitoring, food security and biomedical research.
The incidence of chronic diseases such as diabetes and cardiovascular diseases is increasing worldwide. Increasing population has increased the availability of medical tools for diagnosis of population manifestations in hospitals and pharmacies. Besides, an increase in diagnostic devices equipped with biosensors helps in diagnosing diseases in patients quickly and accurately. The increasing joint venture between semiconductor and medical device companies to develop such device platforms is fueling the growth of the global market.
US Biosensors Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 30.27 billion
Largest Segment
Electrochemical
Fastest Growth
Optical
Growth Rate
8.1% CAGR
To get more reports on the above market click here to Buy The Report
Global Biosensors Market is segmented by Type, Product, Technology, Component, Application and region. Based on Type, the market is segmented into Sensor Patch and Embedded Device. Based on Product, the market is segmented into Wearable Biosensors and Non-Wearable Biosensors. Based on Technology, the market is segmented into Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal Biosensors and Nanomechanical Biosensors. Based on Component, the market is segmented into Bioreceptor Molecules, Biological Element and Transducer. Based on Application, the market is segmented into Poc, Home Diagnostics, Research Labs, Environmental Monitoring, Food & Beverages and Biodefense. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The electrochemical segment occupied the largest market share of around 71.5% in 2023 and is expected to grow at a rapid rate of CAGR of 8.0% from 2024 to 2031. This is in the context of both biochemical and biological methods of measurement and analysis. The reason for their use is low detection limit, wide linear response range, good stability, and repeatability are all advantages of electrochemical biosensors. Electrochemical detection has many advantages over piezoelectric, thermal and optical detection, leading to increased market penetration and adoption.
Robustness, compatibility with new micromanufacturing technologies, ease of use, low cost, disposability, freedom from sample staining, low power requirement is some of the advantages where the optical segment is expected to witness the fastest CAGR from 2024 onwards until 2031. Receptor-cell interaction, fermentation monitoring, structural investigation, concentration, and kinetic equilibrium analysis are all possible in optical biosensors. The optical segment is expected to grow due to the above factors.
The medical device companies segment accounted for the largest share of the market in 2023. Furthermore, the demand for biosensor devices in healthcare continued to drive the segment to a larger share in the global market. In January 2023, DuPont announced that DuPont Livo Healthcare Solutions has partnered with STMicroelectronics to develop a new smart wearable device concept for remote BioSignal monitoring. Medical device companies play an important role in the biosensor market by promoting innovation and commercialization of biosensor technology. These companies are leaders in the development of advanced biosensors for applications such as glucose monitoring, heart health, infection detection etc. Further integration of Vedkans into wearable devices and other healthcare applications is what available to consumers and healthcare professionals.
The contract development and manufacturing organizations (CDMOs) segment is predicted to show the best CAGR during 2024-2031. The increase was due to increased strategic making plans in manufacturing businesses and research institutes. This growth is attributed to analyzing trends inclusive of technological advances in evolved nations, and multiplied manufacturing of medicine by using CDMOs. Contract development and manufacturing units (CDMOs) are important in the biosensor market by providing key services that help take biosensor products from concept to commercialization. CDMO provides expertise in areas such as biosensor design, prototyping, scale-up, and large-scale production. Their role is especially important for start-ups and small businesses that don't have internal manufacturing capabilities. By working in partnership with the CDMO, these agencies can accelerate the development process, ensuring product quality and meeting regulatory requirements.
To get detailed analysis on other segments, Request For Free Sample Report
North America is the dominant region in the global biosensors market. North America held the largest revenue share of over 39.60% in 2023 owing to the presence of key populations and rise in targeted diseases during the forecast period, technological advancements, that the introduction of small diagnostic tools that increase the penetration of electronic medical records into the market. Additionally, the Clean Air Act, Clean Water Act and National Environmental Policy Act all exist in the US. and is expected to boost the regional market.
Increasing prevalence of chronic diseases such as diabetes and cancer among the population is fueling the growth of the market in Asia-Pacific. The region is expected to exhibit the highest CAGR during the forecast period owing to the increasing demand for diagnostic monitoring facilities in healthcare settings. Increasing number of diagnostics will drive the adoption of biosensor-based devices consumption across the globe is growing, driving the market from 2024 to 2031. In 2021, there will be more than 90.0 million people (about twice the population of California) in Southeast Asia aged 20 to 79, and the number is expected to rise to 113.0 million by 2030, according to data from the International Diabetes Federation (IDF).
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Demand for Point-of-Care Testing
Rise in the Advancements in Nanotechnology and Biochemistry
High Cost of Advanced Biosensors
Legal Challenges and Delayed Approval
Request Free Customization of this report to help us to meet your business objectives.
The global biosensors market is highly competitive, with numerous players in the market. An instance of a strategic partnership within the biosensors marketplace is the collaboration among the Abbott Laboratories and Bigfoot Biomedical. The two companies collaborated to develop and commercialize a diabetes management system that combines Abbott's FreeStyle Libre glucose-sensing technology with Bigfoot Biomedical's insulin delivery systems. The aim of the collaboration was to develop a simple and user-friendly solution for diabetics, combining continuous glucose monitoring (CGM) with automatic insulin delivery to create a permissive system. Abbott expertise in biosensors and glucose monitoring, paired with Bigfoot's innovation in insulin management. This strategic partnership, which could dramatically improve patients' lives by providing diabetes management facilitates and enhances glucose monitoring.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to SkyQuest analysis, the global market is a rapidly growing industry that is driven by advances in technology and the increasing demand for accurate and reliable diagnostic tools in various industries. The medical segment dominated the market in 2021, accounting for around 66.5% of the total revenue share. The agricultural segment is expected to grow at the fastest compound annual growth rate (CAGR) during the forecast period. North America dominated the global market in 2022, owing to the increasing demand for point-of-care testing, the rising prevalence of chronic diseases, and the presence of major players in the region. However, the Middle East and Africa region is expected to exhibit the highest CAGR during the forecast period due to the increasing adoption of biosensors in the healthcare and agricultural sectors and the growing demand for personalized medicine.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 30.27 billion |
Market size value in 2032 | USD 61.02 billion |
Growth Rate | 8.1% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Biosensors Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Biosensors Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Biosensors Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Biosensors Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Biosensors Market size was valued at USD 28.9 Billion in 2023 and is poised to grow from USD 31.21 Billion in 2024 to USD 57.88 Billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).
The global biosensors market is highly competitive, with numerous players in the market. An instance of a strategic partnership within the biosensors marketplace is the collaboration among the Abbott Laboratories and Bigfoot Biomedical. The two companies collaborated to develop and commercialize a diabetes management system that combines Abbott’s FreeStyle Libre glucose-sensing technology with Bigfoot Biomedical’s insulin delivery systems. The aim of the collaboration was to develop a simple and user-friendly solution for diabetics, combining continuous glucose monitoring (CGM) with automatic insulin delivery to create a permissive system. Abbott expertise in biosensors and glucose monitoring, paired with Bigfoot's innovation in insulin management. This strategic partnership, which could dramatically improve patients' lives by providing diabetes management facilitates and enhances glucose monitoring. 'Abbott Laboratories (US) ', 'Roche Diagnostics -(Switzerland) ', 'Johnson & Johnson (US) ', 'Medtronic (Ireland) ', 'Siemens Healthcare GmbH (Germany) ', 'GE Healthcare (US) ', 'LifeScan, Inc. (US) ', 'Bio-Rad Laboratories (US) ', 'Nova Biomedical (US) ', 'Dexcom (US) ', 'AgaMatrix, Inc. (US) ', 'Biosensors International Group, Ltd. (Singapore) ', 'Sysmex Corporation (Japan) ', 'F. Hoffmann-La Roche AG (Switzerland) ', 'PTS Diagnostics (US) ', 'Acon Laboratories, Inc. (US) ', 'Medtronic Diabetes (US) ', 'Universal Biosensors, Inc. (Australia) ', 'Analog Devices, Inc. (US) ', 'Lifescan Medical Devices Co., Ltd. (China) ', 'Biosensing Instrument, Inc. (US) ', 'Miraculins Inc. (Canada) ', 'I-SENS, Inc. (South Korea) ', 'LifeSensors, Inc. (US) ', 'GlySens Incorporated (US)', 'August 2023: University of Missouri researchers developed a new technique that uses nanopores to help scientists advance their discoveries in neuroscience, medical biosensors and other medical applications. ', 'February 2023: Northwestern University developed an accurate, cost-effective, and easy-to-use test to detect toxic fluoride in water. The test is a biosensor that uses RNA, DNA, and protein transcripts to emit a signal when a target contaminant is detected. ', 'February 2023: Lino Biotech AG is acquired by Miltenyi Biotech. Lino Biotech is a leader in the development of innovative biosensors for sustainable management of bioresources, measuring bacterial populations in cell & gene therapy industries, and testing non-target reactions in living cells to aid drug discovery.'
The biosensors market is driven by the growing demand for point-of-care (POC) assays, especially in the healthcare industry. Biosensors enable rapid, accurate and portable assays, essential for monitoring chronic diseases, managing acute conditions, and responding to public health emergencies. POC testing and its efficiency leads to its adoption in various settings, from clinical to home care, thereby boosting biosensors market growth.
Increasing Device Deployment for Diabetes Monitoring: The prevalence of diabetes and associated complications is increasing in populations worldwide because of its high prevalence, most people demand early diagnosis and surveillance. Biosensors enable accurate diagnosis and monitoring of treatment and treatment efficacy in diabetic patients due to their precise advantages, such as accurate insulin estimation, cost, and utilization. According to an article published in 2023 by MDPI, traditional analytical methods for insulin detection are time-consuming, expensive, and lack real-time monitoring capabilities, as these factors can lead to production inspection at the point of view and continuous monitoring.
North America is the dominant region in the global biosensors market. North America held the largest revenue share of over 39.60% in 2023 owing to the presence of key populations and rise in targeted diseases during the forecast period, technological advancements, that the introduction of small diagnostic tools that increase the penetration of electronic medical records into the market. Additionally, the Clean Air Act, Clean Water Act and National Environmental Policy Act all exist in the US. and is expected to boost the regional market.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG45J2077
[email protected]
USA +1 351-333-4748